Catalys Pacific, LLC 13F holdings
Catalys Pacific, LLC reported 2 positions with a total reported value of $229.5M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-05. Top holdings by reported value: MLYS Mineralys Therapeutics, Inc. (92.9%), PHAT Phathom Pharmaceuticals, Inc. (7.1%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when Catalys Pacific, LLC files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
2 largest of 2 positions · reported value as of 2026-06-30
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| MLYS Mineralys Therapeutics, Inc. | 7,903,838 | $213.2M | 92.9% |
| PHAT Phathom Pharmaceuticals, Inc. | 1,493,854 | $16.2M | 7.1% |
SEC FORM 13F · Q2 2026 · VALUES AS REPORTED, NOT PRICES
New positions this quarter
Held at 2026-06-30, not at 2026-03-31 · 0 in all · reported value as of 2026-06-30
No new positions.
Sold out
Held at 2026-03-31, gone by 2026-06-30 · 0 in all · reported value as of 2026-03-31
No positions were sold out.
Biggest increases and decreases
Positions held at both quarter ends, by change in shares · reported value as of 2026-06-30
Increases
No position was increased.
Decreases
No position was decreased.
CIK 2011385 · 13F FILINGS ON EDGAR · INFORMATIONAL ONLY
